** Jefferies revises down health imaging firm Pro Medicus' PME.AX near-term growth forecasts, considering the stepped minimum nature of the Trinity contract
** Brokerage trims firm's cardiology contribution estimates, leading to implied market share increase to 14% in FY26, down 15% from previous estimates
** Despite these adjustments, brokerage maintains its A$250 price target and 'Hold' rating
** Stock down 9% YTD
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk;))